Cancer immunology expert and former AACR president Elizabeth Jaffee, MD, FAACR, discusses the latest progress in the research on...
In April 2026, AACR's journals editors highlighted studies on cancer survivors taking GLP-1 agonists, an immunotherapy-boosting bacteria, and more.
Researchers and a patient advocate weighed in on current and emerging treatment options for each stage of triple-negative breast...
At the SABCS 2025 View From the Trenches session, experts discussed how new clinical trial results might transform breast...
At SABCS 2025, studies show some patients with early-stage breast cancer can skip steps like SLNB or MRI without...
In clinical trials presented at SABCS, a mobile health tool and acupuncture helped to improve breast cancer survivors' quality...
Throughout the years, SABCS has shown how tucatinib has progressed into a potential frontline therapy for HER2-positive breast cancer.
A look at recent research on determining breast cancer risk, the impact of lifestyle changes on cancer risk, and...
Adwoa Bemah Boamah Mensah, PhD, received a BIG Cat grant from the AACR to help her efforts to improve...
For June 2025, the editors of AACR's journals highlighted studies on pancreatic cancer interception, breast cancer risk prediction, and...
After Craig Schumpert learned he had lung cancer that had spread to his brain, bones, and lymph nodes, he...